Search Results - "Feutry, F"

Analysis of plasticizers in PVC medical devices: Performance comparison of eight analytical methods by Bernard, L., Bourdeaux, D., Pereira, B., Azaroual, N., Barthélémy, C., Breysse, C., Chennell, P., Cueff, R., Dine, T., Eljezi, T., Feutry, F., Genay, S., Kambia, N., Lecoeur, M., Masse, M., Odou, P., Radaniel, T., Simon, N., Vaccher, C., Verlhac, C., Yessaad, M., Décaudin, B., Sautou, V.

“…A wide variety of medical devices (MDs) used in hospitals are made of flexible plasticized polyvinylchloride (PVC). Different plasticizers are present in…”
Get full text

Prognostic impact of the neutrophil-to-lymphocyte ratio (NLR) on overall survival in patients treated with chemoradiotherapy for head and neck cancer by Makhloufi, S., Lefebvre, G., Sakji, I., Feutry, F., Leroy, T., Penel, N., Coche, B., Fourquet, J., Ghestem, F., Julieron, M., Chevalier, D., Tresch, E.

Get full text

3PC-022 Particulate quality of a controlled atmosphere area. Compliance with good manufacturing practices at rest and during activity, highlighting factors impacting on contamination by Pottier, M, Naveau, M, Villain, A, Strobbe, G, Sakji, I, Feutry, F, Marliot, G

“…Background and importanceThe activity of chemotherapy preparations is constantly evolving:It is increasing (+17% in our centre in 5 years).Particulate quality…”
Get full text

5PSQ-014 Impact of histamine-2 antagonist shortage on the incidence of hypersensitivity reactions to paclitaxel – towards crisis management and a premedication reconsideration in France (PACLIREACT Study) by Strobbe, G, Gaboriau, L, Abele, M, Villain, A, Aelbrecht-Meurisse, C, Carnot, A, Le Deley, MC, Léguillette, C, Sakji, I, Feutry, F, Marliot, G

“…Background and ImportanceAt the beginning of October 2019, an international shortage of ranitidine forced us to adjust paclitaxel-based chemotherapy…”
Get full text

1ISG-011 Reduction of the patient waiting time: what cost for the chemotherapies preparation unit? by Naveau, M, Pottier, M, Sakji, I, Delbey, S, Strobbe, G, Feutry, F, Marliot, G

“…BackgroundOur establishment produces approximately 150 chemotherapies per day for 115 patients. In order to reduce the patient waiting time, we decided to…”
Get full text